Evaluation of adalimumab (ADA) therapy after infliximab (IFX) failure in pediatric Crohn disease (CD) von Alvisi, P, Arrigo, S, A.Barabino, Cucchiara, S, De Giacomo, C, Gennari, M, Guariso, G, Lionetti, P, Miele, E, Ravelli, A, Romano, C, Zuin, G, Knafelz, D, Martelossi, S

Volltext